Focused approach needed to end TB

Addressing the question of whether the international community can eliminate tuberculosis, Arundhati Maitra and Sanjib Bhakta of the Department of Biological Sciences at the University of London write in an opinion piece in the AlertNet News Blog, "With an estimated 8.7 million reported cases and 1.4 million deaths due to TB in 2011, the question above poses one of the most serious challenges faced by the scientific community, health care industry, government and public organizations worldwide." They continue, "However, this year on World TB Day whilst commemorating Dr. Robert Koch's discovery of the germ (Mycobacterium tuberculosis) causing tuberculosis back in 1882, we can share many positive signs."

Maitra and Bhakta provide a brief overview of technological advancements that have aided the global TB response -- such as new diagnostic tools -- as well as a number of existing challenges -- such as detection and a lack of "the necessary infrastructure for fast and accurate point of care detection of TB." They write, "Novel anti-tubercular drug regimen that shorten treatment period is the need of the hour," and add, "Another approach required is in the field of vaccine development." They conclude, "A steady fall in new incidences and mortality caused by drug-susceptible forms of TB has already been observed. A focused approach towards tackling the drug-resistant forms of the disease and its synergistic association with HIV should enable us to reduce the threat of this highly infectious disease on the well-being of mankind" (3/22).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UMass Amherst researcher receives $2.2 million grant to study tuberculosis response